Huberman LabHow to Safeguard Your Hormone Health & Fertility | Dr. Shanna Swan
CHAPTERS
- 0:00 – 23:00
Introduction: Why Hormone Disruptors Threaten Fertility
Huberman introduces Dr. Shanna Swan, outlining her expertise in environmental medicine and reproductive epidemiology, and frames the episode around falling fertility, sperm counts, testosterone levels, and rising reproductive disorders. He emphasizes that Swan will focus not just on risks but on simple, practical steps people can take to reduce exposure and regain some control over their hormone health.
- •Dr. Swan studies how environmental chemicals in food, air, water, cosmetics, and household products affect hormones and reproduction across the lifespan.
- •Global fertility rates, sperm counts, and testosterone are declining while PCOS and other reproductive disorders are increasing.
- •Endocrine‑disrupting chemicals (EDCs) interfere with hormonal pathways like estrogen and testosterone, with both daily and long‑term health consequences.
- •The episode aims to translate complex epidemiology into actionable behaviors for listeners.
- 23:00 – 33:00
What Are Endocrine Disruptors and Why Focus on Them?
Swan defines endocrine‑disrupting chemicals and explains why she concentrates on man‑made compounds that alter hormonal systems. She recounts her path from studying oral contraceptives—deliberate endocrine disruptors—to environmental chemicals, setting up the logic for focusing on hormones as the key organizing principle for understanding these exposures.
- •Endocrine disruptors are chemicals that interfere with the body’s hormones, such as estrogens and androgens, altering development and function.
- •Oral contraceptives are intentional endocrine disruptors; this background informed Swan’s later work on unintentional disruptors in the environment.
- •The central scientific questions are: which hormones, at what dose, in whom, and at what developmental window.
- •Focusing on hormone pathways gives a tractable way to design experiments and interpret effects across species.
- 33:00 – 49:00
Discovery of Phthalate Syndrome in Animals and Humans
On a flight with CDC chemist John Brock, Swan first learns about phthalates and animal data from the National Toxicology Program showing a ‘phthalate syndrome’ in male rats. She explains how critical windows of gestation determine genital masculinization, and how she translated these animal findings into human research linking maternal phthalates to altered male genital development.
- •NTP rat studies showed that feeding pregnant rats certain phthalates caused incomplete masculinization of male offspring: smaller penis, undescended testes, altered epididymis, and shortened anogenital distance (AGD).
- •The effect occurs only if exposure happens within a narrow male programming window in early gestation; outside that window there is no effect.
- •Phthalates enter humans via multiple routes—food, inhalation, dermal absorption—but the initial NTP studies were via food.
- •Swan’s “aha moment” was asking whether this phthalate syndrome also exists in humans and how to ethically detect it.
- 49:00 – 1:10:00
Measuring Human Genital Development: Anogenital Distance (AGD)
Swan describes devising a protocol to measure AGD—the distance from anus to genitals—in human infants, borrowing from 90+ years of animal work. Using stored urine from pregnant women and follow‑up exams of their infants, she connects maternal phthalate metabolites to shorter AGD and other genital changes in boys, establishing the human version of phthalate syndrome.
- •AGD is sexually dimorphic in mammals, typically 50–100% longer in males, reflecting greater genital “real estate” and prenatal androgen exposure.
- •Swan used stored urine from pregnant women to measure phthalate metabolites and invited them back with their babies (~12 months old in the first study) for genital measurements.
- •Technical challenges included defining consistent anatomical landmarks (anoscrotal and anopenile distances) and validating inter‑ and intra‑examiner reliability.
- •Higher maternal levels of the most anti‑androgenic phthalates (DEHP, DBP, BBzP) predicted significantly shorter male AGD, smaller penis and scrotum, and less testicular descent.
- 1:10:00 – 1:33:00
Replication, Critical Windows, and Linking AGD to Sperm Count
To strengthen the evidence, Swan launches a second, more rigorous study (TIDES) with timed urine samples each trimester and infant exams at birth, confirming the phthalate–AGD link. She then tests whether adult AGD predicts sperm count in young men and finds that longer AGD is associated with higher sperm counts, supporting AGD as a lifelong marker of prenatal androgen exposure and male reproductive capacity.
- •TIDES collected maternal urine early in pregnancy and in all trimesters, and measured AGD at birth, closely mirroring the animal protocols.
- •Findings replicated: higher anti‑androgenic phthalates again produced shorter AGD and more female‑like genital proportions in male infants.
- •Assuming “AGD is forever” when adjusted for body size, Swan recruited college men, measured their AGD and sperm counts, and found a positive correlation.
- •Subsequent clinic data (Eisenberg) showed men who had fathered children had longer AGD than similarly evaluated men who had not.
- 1:33:00 – 1:51:00
Sperm Count Decline: Methods, Confounders, and Functional Impact
Swan unpacks her landmark analyses showing a ~50% decline in sperm counts over 50 years. As the lone statistician on a National Academy of Sciences panel, she stress‑tested earlier data against all plausible confounders. After replicating and extending the analyses, she concluded the decline is real and too fast to be genetic, implying environmental causes. She then explains how sperm count impacts real‑world fertility.
- •Swan re‑analyzed a Danish claim of 50% sperm decline, adjusting for lab methods, subject characteristics (obesity, smoking), and other confounders; the decline slope was unchanged.
- •A subsequent independent selection of studies yielded the same trend, convincing her the effect is robust.
- •Because the change occurs over about two generations, it cannot reasonably be explained by genetics alone, implicating environmental factors.
- •Time‑to‑pregnancy studies show that below ~45–50 million/mL sperm, conception probability quickly drops; above ~75–100 million/mL, higher counts do not confer extra benefit.
- •Thus, many men are moving into a range where sperm count materially affects their chances of conceiving.
- 1:51:00 – 2:08:00
Pesticides, Atrazine, and Fertility Across Species
Exploring other classes of endocrine disruptors, Swan describes a multi‑city US study showing men in agricultural Missouri had about half the motile sperm of men in Minneapolis, and pesticide metabolites were higher in the low‑sperm group. Huberman and Swan then discuss atrazine, a widely used herbicide shown by Tyrone Hayes to induce male frogs to mount other males, underscoring that sexual differentiation of brain and behavior is also chemically vulnerable.
- •Studying partners of pregnant women in four US cities, Swan found men in a high‑pesticide region (central Missouri) had roughly half the moving sperm of men in Minneapolis.
- •Within Missouri, men with poorer semen parameters had significantly higher levels of five triazine pesticides (including atrazine) in their urine.
- •Atrazine is one of the most widely used herbicides globally and has been shown in frogs to alter sexual development and behavior (e.g., males mounting males).
- •These data support a broader concept: the same chemicals harming humans are affecting wildlife, contributing to biodiversity loss and species endangerment.
- 2:08:00 – 2:35:00
Sexual Dimorphism, Behavior, and Politically Sensitive Findings
The conversation turns to sexual dimorphism of the brain and behavior. Using AGD and play behavior questionnaires, Swan shows that prenatal hormone disruptions nudge distributions rather than determine outcomes. Boys exposed to higher phthalates show less male‑typical play, and daughters of women with PCOS show more male‑typical AGD. They stress that these are statistical tendencies in overlapping distributions, not rigid destinies.
- •AGD is sexually dimorphic in nearly all mammals (exceptions: hyena, elephant), reflecting underlying hormonal programming.
- •Daughters of women with PCOS (high maternal androgens) have longer, more male‑like AGD, confirming AGD as a bidirectional marker of prenatal androgen exposure.
- •At around age 4, boys with higher in‑utero phthalate exposure display less rough‑and‑tumble, more traditionally feminine play preferences on the PSAI questionnaire.
- •These effects persisted after controlling for older siblings’ sex and parental attitudes toward gendered play.
- •The authors emphasize distributions overlap: exposure shifts probabilities and tendencies, not absolute identities or capabilities.
- 2:35:00 – 2:55:00
Practical Exposure Sources: Food, Water, Plastics, Fragrances, Cookware
Responding to audience‑relevant concerns, Swan catalogs the main controllable sources of endocrine disruptors in daily life. She emphasizes food and drink contact materials, fragranced products, non‑stick cookware, and clothing/furniture as high‑yield targets. She also explains the regulatory bait‑and‑switch of BPA‑free products using equally problematic analogs BPS and BPF.
- •Top controllable sources: food packaging and storage (plastic, can linings), beverages in cans/plastic, microwaving in plastic, non‑stick pans (PFAS), fragranced cosmetics and cleaners, and treated textiles/furniture.
- •Phthalates are added to hold scent and color and to increase absorption; any product with fragrance (perfume, shampoo, lotion, soap, detergents, air fresheners) likely contains them.
- •BPA in can linings is a major exposure route; BPA‑free labels often hide substitution with BPS/BPF, which appear similarly harmful.
- •Heating plastic (microwaving, leaving bottles in hot cars) accelerates leaching of phthalates and bisphenols into food and water.
- •Swan prefers distilled water in glass, buys organic and loose/bulk produce (cheaper and avoids plastic packaging), and increasingly pays attention to textile and dye exposures, especially in tight, sweaty workout clothing.
- 2:55:00 – 3:19:00
Intervention Study: Swapping Products to Lower Body Burden
Swan outlines an intervention trial (also central to an upcoming documentary) involving six infertile couples. Using the startup Million Marker, the team inventories every product the couples use, then provides a curated box of safer replacements and coaching on behavior changes. Early feedback suggests people find the changes doable and even feel better, and sperm and conception outcomes are being formally analyzed.
- •Million Marker collects detailed product inventories (personal care, cleaners, cookware, storage, etc.) and tests users’ urine for multiple EDC metabolites.
- •For the film, couples with 12+ months of infertility received personalized counseling and a box of alternative products (e.g., glass/steel containers, non‑stick replacements, fragrance‑free cleaners and cosmetics).
- •Intervention deliberately omitted obesity or exercise changes to isolate the effects of product and exposure shifts.
- •Participants widely reported improved sleep, energy, and satisfaction with the new routines and wanted to continue after the study.
- •Sperm count and fertility outcomes were measured pre‑ and post‑intervention; specific results remain embargoed until publication.
- 3:19:00 – 3:46:00
Regulation, REACH vs. US, and the Limits of ‘Safe’ Substitutes
The discussion pivots to policy. Swan contrasts the EU’s REACH framework—requiring proof of safety before market entry—with the US approach of ‘approve first, worry later.’ She gives examples of hard‑won, narrow victories (e.g., DEHP bans in IV bags) and the challenge of substitute chemicals whose safety is unknown, illustrating why personal behavior remains crucial even with regulatory progress.
- •REACH forces companies in Europe to demonstrate safety before marketing new chemicals; the US generally allows market entry first, then reacts to harm data.
- •Removing a single bad actor (e.g., DEHP from IV bags) took major effort and only addresses one chemical in one product category.
- •A manufacturer (B. Braun) built a factory to produce DEHP‑free IV bags with polyolefin, but the full health profile of polyolefin is still uncertain.
- •Even in healthcare, phthalates remain pervasive in tubing and bags; patients receiving dialysis, chemotherapy, or IV fluids are directly exposed.
- •Swan doubts that US adoption of a REACH‑like system is imminent, given industry resistance and the cost–complexity of pre‑market testing for tens of thousands of chemicals.
- 3:46:00 – 4:18:00
Prenatal, Multi‑Generational Effects and the Fertility Crisis
Swan underscores that prenatal exposures can permanently reduce sperm counts and ovarian function and that germ cells for future generations are present in the developing fetus. She situates human fertility decline alongside wildlife infertility and extinction, arguing that falling birth rates are not just about choice or economics. Assisted reproductive technologies may bridge some gaps, but they raise their own scientific and ethical questions.
- •Men whose mothers smoked during pregnancy have ~50% lower sperm counts, a deficit that appears irreversible; adult lifestyle impacts (e.g., smoking) can partially reverse once the behavior stops, but prenatal hits cannot.
- •Research suggests exposures during pregnancy can affect at least three generations (mother, fetus, fetus’s germ cells) and possibly more via epigenetic mechanisms.
- •Global total fertility rates have dropped toward or below the replacement level (2.1 children per woman) in many countries; some (e.g., South Korea ~0.78, Japan ~1.0) are far below.
- •Non‑human species show parallel fertility declines and rising extinction risk that cannot be explained by delayed parenting or contraception, further implicating environmental toxicants.
- •Assisted reproductive technologies (IVF, ICSI, three‑parent mitochondrial replacement, in‑vitro gametogenesis) may help individuals conceive but raise questions about offspring health and population‑wide reliance on technology to reproduce.
- 4:18:00
Actionable Steps and Final Reflections
In closing, Swan and Huberman synthesize practical strategies and broader implications. Swan highlights key behaviors she personally follows and points listeners to her book ‘Countdown’ and resources like Environmental Working Group and Million Marker. The conversation ends by emphasizing awareness, incremental change, and the importance of protecting future generations through today’s choices.
- •Swan’s personal practices include: distilling drinking water and storing it in glass, buying organic when possible, minimizing plastic contact with food, avoiding fragranced products, and increasingly scrutinizing textiles and dyes.
- •Tools like Environmental Working Group’s consumer guides and services like Million Marker help individuals audit and improve product choices.
- •Water‑soluble EDCs (many phthalates, bisphenols) clear quickly if intake stops; fat‑soluble and PFAS chemicals persist, but reducing current exposure still matters.
- •Awareness itself is powerful; once people understand the stakes, they tend to find creative, cost‑sensitive ways to reduce exposure.
- •Swan’s book ‘Countdown’ devotes two chapters to concrete exposure‑reduction strategies, and she encourages anyone planning or carrying a pregnancy to treat this as a serious, multi‑generational responsibility.
